<DOC>
	<DOC>NCT02927990</DOC>
	<brief_summary>The new software package is intended to assist the physician in imaging the coronaries during percutaneous coronary interventions. This study investigates the amount of contrast used during percutaneous coronary interventions with the aid of the new software package. The results of the study will be compared with control group data (before the new software package was installed or after it was removed) to define a possible contrast reduction.</brief_summary>
	<brief_title>Contrast Volume Reduction During PCI With the Use of a New Assisting Software Package</brief_title>
	<detailed_description />
	<mesh_term>Coronary Stenosis</mesh_term>
	<mesh_term>Coronary Occlusion</mesh_term>
	<criteria>Subject undergoing a percutaneous coronary intervention. Subject 18 years of age or older, or of legal age to give informed consent per state or national law. Subject undergoing an emergency treatment Primary angioplasty for acute ST segment elevation myocardial infarction. Subject with contrast allergies Subject with severe kidney disease (eGFR &lt; 40 by Modification of Diet in Renal Disease (MDRD)/Cockcroft Gault clearance formula and/or upon decision by investigator) Subject participates in a potentially confounding drug or device trial during the course of the study. Prisoners, people who cannot legally give consent, pregnant women and breastfeeding women.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>